Project Details
Description
A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF THREE DOSAGE REGIMENS OF MP-376 SOLUTION FOR INHALATION GIVEN FOR 28 DAYS TO STABLE CYSTIC FIBROSIS PATIENTS
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/08 → 8/31/10 |
Funding
- MPEX PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.